SUMMARY
Pathogen-associated molecular patterns (PAMPs) elicit basal defense responses in plants, and, in turn, pathogens have evolved mechanisms to overcome these PAMP-induced defenses. To suppress immunity, the phytopathogenic bacterium Pseudomonas syringae secretes effector proteins, the biochemical function and virulence targets of which remain largely unknown. We show that HopAI1, an effector widely conserved in both plant and animal bacterial pathogens, inhibits the Arabidopsis mitogen-activated protein kinases (MAPKs) activated by exposure to PAMPs. HopAI1 inactivates MAPKs by removing the phosphate group from phosphothreonine through a unique phosphothreonine lyase activity, which is required for HopAI1 function. The inhibition of MAPKs by HopA1 suppresses two independent downstream events, namely the reinforcement of cell wall defense and transcriptional activation of PAMP response genes. The MAPKs MPK3 and MPK6 physically interact with HopAI1 indicating that they are direct targets of HopAI1. These findings uncover a mechanism by which Pseudomonas syringae overcomes host innate immunity to promote pathogenesis.
INTRODUCTION
Plants are known to activate defenses in response to nonspecific elicitors from diverse microbes (Boller, 1995) . Studies in both animal and plant innate immunity in recent years have indicated that these elicitors constitute pathogen-associated molecular patterns (PAMPs), triggering basal defenses in the host (Nü rnberger and Lipka, 2005; Zipfel and Felix, 2005) . Because PAMPs also exist in nonpathogenic microbes, they have also been referred to as microbe-associated molecular patterns (MAMPs; Ausubel, 2005) . PAMP-triggered plant defenses form a formidable layer of resistance deterring numerous potential pathogens (Kang et al., 2003; Li et al., 2005) . An emerging consensus is that pathogens infecting the modern day land plants have evolved mechanisms to overcome the PAMP-induced defenses in their respective host plants (Chisholm et al., 2006) . Therefore, PAMP-triggered defenses are at the core of understanding both plant disease resistance and bacterial pathogenicity.
The best understood PAMP of plant pathogens is arguably flg22, a conserved peptide derived from Pseudomonas syringae flagellin (Felix et al., 1999) . Flg22 is perceived by the receptor kinase FLS2 in Arabidopsis to stimulate cell wall defenses exemplified by callose deposition (Felix et al., 1999; Gomez-Gomez and Boller, 2000) , ethylene production (Felix et al., 1999; Liu and Zhang, 2004) , and reprogramming of transcriptome Navarro et al., 2004; Thilmony et al., 2006) . Immediately after the exposure to flg22, plants activate a rapid but transient oxidative burst (H 2 O 2 production; Felix et al., 1999) and mitogen activated protein kinases (MAPKs) MPK3 and MPK6 (Asai et al., 2002) . However, it is not known if a causal relationship exists between MAPK activation and oxidative burst.
Gram-negative bacteria use a specialized type III secretion system to deliver a repertoire of effector proteins into host cells to subvert host immunity, thereby promoting parasitism (Alfano and Collmer, 2004) . Several plant proteins are known to interact with P. syringae effectors (Mackey et al., 2002; Axtell and Staskawicz, 2003; Mackey et al., 2003; Shao et al., 2003; Nomura et al., 2006) . However, thus far only one of these, an immunity-associated protein in Arabidopsis thaliana, is known to be targeted by the bacterial effector to mediate virulence (Nomura et al., 2006) . In addition, we have only rudimentary knowledge of PAMP-signaling mechanisms, all of which has impeded our understanding of bacterial virulence mechanisms.
We have shown previously that the P. syringae HopAI1 protein belongs to an effector family widely conserved in both animal and plant pathogenic bacteria (Li et al., 2005) . Supporting an important role of this effector family in infection, the Salmonella typhimurium effector SpvC, a HopAI1 family member, is required for bacterial virulence in mice (Gulig and Chiodo, 1990) . Expression of HopAI1 in plants enhances disease susceptibility to P. syringae and suppresses flg22-induced transcription of Arabidopsis NHO1, a gene required for basal resistance to P. syringae (Kang et al., 2003; Li et al., 2005) . These results indicate that HopAI1 targets the PAMP-mediated signaling to suppress host defenses. The biochemical function and host target of HopAI1 and its family members remain unknown.
Here we show that HopAI1 directly inactivates MPK3 and MPK6 by dephosphorylation and consequently suppresses flg22-induced gene expression, oxidative burst, and callose deposition, resulting in increased disease susceptibility in plants. We recently found that the Shigella effector OspF, a HopAI1 family member, cleaves the C-OP bond at the phosphothreonine residue of animal MAPK (Li et al., 2007) . HopAI1 carries the same activity to remove the phosphate group from phosphothreonine of Arabidopsis MAPKs. Mutational analysis indicates that this enzymatic activity is required for HopAI1 to suppress flg22-triggered MAPK activation and immune responses.
RESULTS
hopAI1 Contributes to Pseudomonas syringae pv. tomato Virulence in Plants The hopAI1 genes carried by the two previously known Pseudomonas strains P.s. pv. tomato DC3000 and P.s. pv. syringae B728A appear to be inactive (Lindeberg et al., 2006; Vinatzer et al., 2006) . To determine if hopAI1 is a functional gene in any Pseudomonas strains, we surveyed 26 strains for sequences crosshybridizing the P.s. pv. tomato DC3000 hopAI1. All 14 P. syringae pv. tomato strains tested contained hopAI1 sequence (Figure S1A) , suggesting that hopAI1 plays an important role in P. syringae. pv. tomato. P.s. pv. tabaci R1152 race 0 and P.s. pv. glycinea race 0 contained clear but weaker hybridizing sequences, suggesting the presence of homologous sequences ( Figure S1A ). In contrast, other strains did not carry homologous sequences. Northern analysis was used to determine if any of the P. syringae. pv. tomato strains carried an active hopAI1 gene. At least two P.s. pv. tomato strains, 0288-9 and 0488-5, actively transcribed hopAI1 mRNA in the minimal medium that is known to induce P. syringae type III effectors ( Figure S1B ).
To determine if HopAI1 plays a role in bacterial virulence, we generated a knockout mutant in strain 0288-9 by using homologous recombination. Because 0288-9 is only modestly virulent on Arabidopsis but highly virulent on tomato plants, we tested the ability of the mutant strain to grow in tomato plants. The mutant bacteria consistently multiplied to a lower level compared with WT bacteria ( Figure 1A) . The difference is statistically significant (Student's t test, p value %0.01), indicating a positive role of hopAI1 in 0288-9 virulence.
HopAI1 Suppresses Both PAMP-Induced Gene Expression and Callose Deposition
Previously we showed that estrogen-inducible expression of a FLAG-tagged HopAI1 transgene in plants enhanced susceptibility to a nonpathogenic P. syringae mutant (Li et al., 2005) , suggesting a loss of PAMP-induced resistance. We examined flg22-induced disease resistance in plants expressing HopAI1. Pretreatment of flg22 protects Arabidopsis plants from a subsequent infection by virulent bacteria . While the flg22-pretreatment completely inhibited the multiplication of the virulent P. syringae strain DC3000 in the wild-type plants, the same treatment did not protect in the HopAI1-expressing plants ( Figure 1B ), indicating that HopAI1 completely suppresses disease resistance activated by flg22.
To understand the function of HopAI1 in plants, we sought to characterize in detail the flg22-induced gene expression and callose deposition when HopAI1 is directly expressed in plants. Figure S2A shows that transient expression of a FLAG-tagged HopAI1 in protoplasts blocked the flg22-induced expression of the FRK1-LUC reporter gene. FRK1 encodes a receptor-like kinase that is induced rapidly in response to PAMPs (Asai et al., 2002) . The suppression is not caused by a general disruption of cellular activities, because HopAI1 does not affect the LUC reporter gene expression under the control of the CaMV 35S promoter ( Figure S2B ). We further expanded this study in HopAI1 transgenic plants by examining the expression of flg22-inducible genes including FRK1, WRKY22, WRKY29, At1g13110, At1g30700, At2g35930, At2g39200, At5g39580, and At5g44910 (Asai et al., 2002 ; http://Arabidopsis.org/info/expression/ ATGenExpress.jsp). These genes encode functionally diverse proteins and serve as a good survey of gene expression profiles. The expression of HopAI1 reduced flg22-induced expression of all genes tested ( Figures 1C) . The stronger suppression of flg22-induced genes by HopAI1 in protoplasts than transgenic plants might be caused by higher-level HopAI1 expression associated with this transient assay. The estradiol-inducible expression of HopAI1 also blocked flg22-induced callose deposition ( Figure 1D ). PAMP-induced callose deposition is required for Arabidopsis resistance to P. syringae bacteria (Kim et al., 2005) . These analyses indicated that the plantexpressed HopAI1 broadly suppresses flg22-induced defenses.
HopAI1 Suppresses Early Signaling Events
The suppression of callose deposition and defense gene expression suggested that HopAI1 targets an early step of the PAMP-induced signaling pathway. We thus tested the effect of HopAI1 on two known signaling events: MAPK activation and transient oxidative burst, both occurring within less than 5 min after flg22 stimulation. Consistent with the previous report (Felix et al., 1999) , wild-type plants treated with flg22 displayed a rapid and transient accumulation of H 2 O 2 within 5 min (Figure 2A ), whereas the fls2 mutant displayed no detectable production of H 2 O 2 (data not shown). The estradiol-induced expression of HopAI1 in plants completely abolished flg22-induced accumulation of H 2 O 2 . The flg22-treatment increased MAPK activities attributed to MPK3 and MPK6, as indicated by the lack of corresponding activities in atmpk3 and atmpk6 mutants ( Figure 2B ). The expression of HopAI1 completely abolished both MPK3 and MPK6 activities ( Figure 2B ). The diminished MAPK activity was not caused by a reduced MPK3 and MPK6 protein levels as indicated by western analysis ( Figure 2B ). Transient expression of HopAI1 in protoplasts also abolished flg22-induced MAPK activity (see below). These results are surprising, as a recent paper by He et al. (2006) reported that HopAI1 does not inhibit MAPKs. An examination of the annotated hopAI1 sequence suggested that the discrepancy might be caused by an extra N-terminal sequence ( Figure S3A ) present in our construct but missing in the annotated sequence and the construct used by He et al. (2006) . Because this sequence is highly conserved in all the HopAI1 family members in various bacteria, the predicted amino acid sequence in the P. syringae database is likely annotated incorrectly. To determine if the N-terminal sequence is required for the activity, an N-terminal truncated construct (DNHopAI1) lacking this sequence was generated and expressed in protoplasts. However, DNHopAI1 still abolished the flg22-induced MAPK activity ( Figure S3B ), indicating that this N-terminal sequence is dispensable for MAPK inhibition. In total, we conducted 8 independent assays with transgenic HopAI1 plants and 8 assays with protoplasts expressing sequenceconfirmed full-length (3 clones) and DNHopAI1 (2 clones) constructs. In each case, the flg22-induced MAPK activity was abolished. We thereby conclude that HopAI1 inhibits the MAPK activation. The suppression of oxidative burst and inhibition of MAPK indicate that HopAI1 targets a very early step in the PAMP-signaling pathway to block host defenses.
MAPKs Act Upstream of Oxidative Burst
It was proposed that ROI produced during oxidative burst might act upstream to activate MAPKs (Kovtun et al., 2000) . It is therefore possible that HopAI1 targets a host protein(s) required for oxidative burst that consequently inhibits MAPK. Alternatively, MAPK may act upstream of ROI production.
To determine if oxidative burst acts upstream of MAPK activation, we first determined the source of ROI production in flg22-induced tissues. In plants, NADPH oxidases, peroxidases, and ROI scavenging systems can all contribute to the increase of ROIs in response to pathogen infection (Torres et al., 2006) . Arabidopsis contains 10 genes encoding NADPH oxidases named respiratory burst oxidase homologs (Atrboh; . The AtrbohD and AtrbohF are required for ROI production in plants challenged with incompatible pathogens (Torres et al., 2002) . A recent study shows that ROIs produced by AtrbohD and AtrbohF suppress cell death . Whether these two genes play a role in PAMP-induced defenses has not been examined. We therefore tested if they are required for ROI production in response to flg22. In contrast to the strong accumulation of H 2 O 2 in the wild-type plants, the atrbohD mutant was completely impaired in this oxidative burst ( Figure 3A ). The atrbohF mutant showed a minor reduction in H 2 O 2 accumulation. The results indicated that AtrbohD is essential for flg22-induced oxidative burst, whereas AtrbohF plays a minor role.
The flg22-induced callose deposition was examined in the atrbohD mutant plants. In contrast to the strong flg22-induced callose deposition in the wild-type plants, the atrbohD mutant exhibited significantly reduced callose deposition (approximately 16% of the wild-type; Figure 3B) , suggesting that the AtrbohD-dependent ROI production mediates callose deposition. Consistent with this possibility, pretreatment of the wild-type plants with diphenylene iodonium (DPI), a NADPH oxidase inhibitor, abolished the flg22-induced callose deposition (Figure S4 ). Together these results demonstrated that AtrbohD ROI regulates cell wall defense exemplified by callose deposition.
We next determined if flg22-induced gene expression was compromised in the atrbohD mutant by northern analysis. Interestingly, both the wild-type and atrbohD mutant plants showed normal induction of all genes tested (Figure S5 ). As several of these genes are induced downstream of MPK3 and MPK6 , the results suggest that AtrbohD is not required for MAPK activation. Indeed, the flg22-induced MAPK activation was completely normal in the atrbohD mutant ( Figure 3C ), indicating that the AtrbohD-dependent ROI production is either (B) HopAI1 suppresses PAMP-triggered activation of MPK3 and MPK6. WT, HopAI1 transgenic, and the atmpk6 (m6) and atmpk3 (m3) mutant plants (carrying T-DNA insertions in respective genes) were presprayed with H 2 O (À) or estradiol, treated with flg22 for 10 min, and protein was extracted for in-gel kinase assay using myelin basic protein as a substrate. Equal amounts of extracts were also subjected to western blot analysis using anti-FLAG, anti-MPK3, and anti-MPK6 antibodies. The arrow indicates the position of MPK6. The amounts of protein loaded are indicated by the Coomassie Blue staining of Rubisco. too low or too transient to activate MAPKs. These analyses indicated that AtrbohD is only required for a subset of defenses. Consistent with this conclusion, the atrbohD mutant is partially compromised in flg22-induced disease resistance as determined by flg22-protection assay (Figure S6) . Together these results suggested that the AtrbohD-dependent ROI production occurs either downstream or independent of MAPK activation.
If MPK3 and MPK6 act upstream of AtrbohD ROI, the activation of these MAPKs is expected to induce callose deposition in the absence of PAMPs. We therefore tested if constitutive activation of MPK3 and MPK6 by the constitutive active MKK5 (MKK5 DD ; Liu and Zhang, 2004 ) is sufficient to induce callose. Indeed, expression of MKK5 DD under the control of a dexmethasome (Dex)-inducible promoter resulted in strong callose deposition in the absence of PAMPs ( Figure 3D ). Because constitutive activation of MPK3 and MPK6 by MKK5 is known to induce the transcription of flg22-inducible genes including FRK1, WRKY22 and WRKY29, it is evident that MPK3 and MPK6 are responsible for both cell wall defenses and gene regulation. We therefore conclude that MAPKs act upstream of AtrbohD, with the latter mediating the cell wall defense pathway.
HopAI1 Directly Targets MPK3 and MPK6 The analyses described above raised the possibility that HopAI1 act directly on components of the MAPK cascade. Because MPK3 and MPK6 can be activated by the expression of constitutive active form of MEKK1 (DMEKK1; Asai et al., 2002) or MKK5 DD (Liu and Zhang, 2004) , we ex- Protein pull-down assay was carried out to determine if HopAI1 directly binds MPK3 and MPK6 in vitro. GSTHopAI1 was coexpressed with His-tagged MPK3 or MPK6 in E. coli, purified with glutathione agarose, and the pull-down products were tested for the presence of MPK3 or MPK6 with western blot. GST-HopAI1, but not GST alone, copurified with MPK3 and MPK6 ( Figure 4B ), indicating a direct interaction between HopAI1 and the two MAPKs. Coimmunoprecipitation was used to verify if such an interaction occurs in vivo. Protein extracts expressing HopAI1-FLAG was precipitated with an argorse-conjugated anti-FLAG monoclonal antibody. Subsequent western blot analysis detected MPK3 and MPK6 in the immune complex ( Figure 4C) for 20 min completely abolished the MAPK activity, whereas the incubation with BSA did not ( Figure 5A ). Significant reduction of the MAPK activity was observed within less than 30 s of incubation with HopAI1 ( Figure 5A , left panel). As little as 20 ng HopAI1 was needed to significantly reduce the MAPK activity ( Figure 5A , right panel). Because HopAI1 7-245 and the MAPKs were separated in the denaturing gel prior to the activity assay, the lack of MBP phosphorylation is indicative of a covalent inactivation of MPK3 and MPK6 by HopAI1, most likely by the removal of phosphate groups required for MAPK activity. To test this possibility, we used recombinant MKK5 DD -His protein to phosphorylate GST-MPK3 and GST-MPK6. The phosphorylated MAPKs were then treated with the purified HopAI1 7-245 protein or BSA, and the level of dual phosphorylation of the TXY motif of MAPKs was detected with anti-phospho-ERK antibodies. Figure 5B shows that the amounts of phosphorylation in both MPK3 and MPK6 were significantly reduced in the presence of HopAI1 7-245 , but not BSA. Together, these results demonstrated that HopAI1 inactivates MAPKs by dephosphorylation. To further investigate the enzymatic activity of HopAI1 in dephosphorylating MAPKs, a synthetic MPK6 phosphopeptide carrying p-threonine and p-tyrosine at the TXY motif was incubated with recombinant HopAI1 7-245 , and the generation of free phosphate was measured. Indeed, the HopAI1 protein displayed a potent activity in removing the phosphate group from the phosphopeptide ( Figure S7 ). In a separate study, we found that Shigella flexneri effector OspF targets animal MAPKs ERK1/2, JNK, and P38 (Li et al., 2007) . Unlike protein phosphatases that remove the phosphate group at the CO-P bond, OspF is an enzyme that specifically cleaves the C-OP bond on phosphothreonine of ERK2 TXY motif. We named this novel enzyme as phosphothreonine lyases. The HopAI1 protein appears to have similar activity toward ERK2 synthetic phosphopeptide. We therefore tested if HopAI1 possesses phosphothreonine lyase activity toward plant MAPK peptide. The synthetic phosphopeptide corresponding to the MPK6 TXY motif was incubated with HopAI1, and the products were subjected to tandem mass spectrum analysis. The HopAI1 treatment reduced , and the mass of the resulting peptides was compared with untreated peptides by mass spectrometry. (E) HopAI1
His102Ala does not inhibit MAPK activation. Two independent transgenic lines carrying FLAG-tagged HopAI1 His102Ala (m-5 and m-7) in the T1 generation were induced by estradiol, treated with flg22 peptide, and MAPK activity was compared with that in WT and transgenic plants expressing the WT HopAI1. The amounts of HopAI1-FLAG, MPK3, and MPK6 (arrow) protein were determined with the indicated antibodies. A representative protein blot was stained with Ponceau S to show equal loading of protein.
(F) The conserved amino acid required for phosphothreonine lyase activity is necessary for HopAI1 to suppress flg22-induced gene expression. Protoplasts prepared from WT plants were cotransfected with the FRK1-LUC reporter construct and WT HopAI1, HopAI1 His102Ala or an empty vector.
Protoplasts prepared from NHO1-LUC transgenic plants were transfected with WT HopAI1, HopAI1 His102Ala or an empty vector. The transfected protoplasts were induced with flg22 for 3 hr for FRK1-LUC and 6 hr for NHO1-LUC before the LUC activity was determined.
the mass of phosphothreonine from 181 Da to 83 Da ( Figure 5C ). In contrast, the phosphotyrosine residue is not modified by HopAI1, indicating that HopAI1 specifically cleaves the C-OP bond of phosphothreonine of the MPK6 peptide. To determine if HopAI1 also removes the hydroxyl group of unphosphorylated threonine, a synthetic unphosphorylated MPK6 peptide was incubated with HopAI1, and mass spectrometry was used to determine the mass of the product. While the HopAI1 treatment reduced the phosphopeptide by 98 dalton, the same treatment did not alter the unphosphorylated peptide ( Figure 5D ). Thus, the enzymatic activity was specific to phosphothreonine, but not unphosphorylated threonine.
HopAI1 Phosphothreonine Lyase Activity Is Required for Defense Inhibition
The conserved histidine residue (OspF
His104
) was found to be required for the enzymatic activity of OspF (Li et al., 2007) . To test if this residue is required for the function of HopAI1, we introduced a corresponding mutation (His102Ala) into HopAI1 and tested transgenic plants expressing HopAI1
His102Ala . Two independent transgenic lines were tested for MAPK activation in response to flg22. As expected, both mutant lines showed nearly normal MAPK activation ( Figure 5E ). We further tested if this residue is required for HopAI1 to inhibit flg22-induced gene expression in protoplasts. As shown in Figure 5F , while the WT HopAI1 diminished the expression of FRK1-LUC to 8% of the control and NHO1-LUC to 22% of the control, the HopAI1
His102Ala mutant only slightly reduced the expression of FRK1-LUC (62% of the control) and has no effect on NHO1-LUC expression. These results indicate that the phosphothreonine lyase activity is required for HopAI1 to suppress flg22-induced defenses.
DISCUSSION
Earlier reports have provided controversial results concerning the role of the HopAI1 family effectors on MAPK signaling Zurawski et al., 2006) . In this study, we systematically determined the role of HopAI1 in defense suppression and its biochemical function. This led to the identification of MPK3 and MPK6 as its targets. HopAI1 inhibits flg22-induced immunity by directly dephosphorylating MPK3 and MPK6. Whether HopAI1 also inhibits other Arabidopsis MAPKs remains to be determined. Following the submission of this paper, Arbibe et al. (2007) reported that OspF acts as a protein phosphatase to dephosphorylate animal MAPKs. However, the HopAI1 family effectors do not share remote similarity with known protein phosphatases. Protein structural study indicated that SpvC does not carry any known phosphatase fold (L.C., H. Wang, and J.C., unpublished data). As demonstrated in Figure 5 and Li et al. (2007) , the HopAI1 family effectors inactivate MAPKs through their phosphothreonine lyase activity, underscoring a new mechanism by which pathogenic bacteria promote virulence. The requirement of a phosphorylated threonine suggests that HopAI1 protein only attacks the C-O bond weakened by the phosphate group. The fundamental difference between this new enzyme and protein phosphatases is that the former results in a threonine residue lacking the hydroxyl group, preventing the rephosphorylation of MAPKs. Indeed, OspF-treated animal MAPKs was not rephosphorylated by MEK (Li et al., 2007) . P. syringae carries a large number of type III effectors. However, little is known about how these effectors promote virulence in the plant cell. The Arabidopsis adenosine diphosphate ribosylation factor guanine nucleotide exchange factor AtMIN7 is the only plant protein known to be targeted by a bacterial effector for virulence (Nomura et al., 2006) . In Arabidopsis, P. syringae effectors AvrPto and AvrPtoB are able to inhibit MAPK signaling pathway, but their targets and mechanism remain unknown . Another P. syringae effector, HopD2, is a tyrosine phosphatase that is similar to the Yersinia effector YopH (Bretz et al., 2003; Espinosa et al., 2003) . However, this effector was shown not to inhibit MPK3 and MPK6 , and its host target remains unknown. The work described here shows that HopAI1 plays an important role in bacterial virulence by directly targeting MAPKs, re-enforcing the notion that MAPK activation is central to plant PAMP-induced immunity. The use of HopAI1 transgenic plants led to the identification of the novel biochemical function of this effector. HopAI1 inactivates MAPKs through an unconventional phosphothreonine lyase activity unique to bacterial effectors, underscoring an ingenious strategy evolved in bacteria to modulate host defense signaling.
The regulation and role of the transient oxidative burst in PAMP-induced plant defenses had been unclear. ROIs generated during plant-pathogen interactions are thought to act as a secondary signal to regulate a diverse array of plant responses including Ca 2+ influx, hypersensitive response, MAPK activation, and defense gene induction (Doke, 1983; Jabs et al., 1996; Mori and Schroeder, 2004; . Recent studies suggested a complex interaction between the MAPK pathway and rboh-dependent ROI production (Desikan et al., 2001; Samuel and Ellis, 2002; Rentel et al., 2004) . Although it is possible that HopAI1 may inactivate phosphorylated proteins in addition to MAPKs, the most plausible interpretation of the data is that MAPKs act upstream of the AtrbohD-dependent ROI production during PAMP signaling. This is consistent with an earlier study indicating that activation of MAPK by the constitutive active MKK5 DD mutant results in H 2 O 2 production (Ren et al., 2002) . The AtrbohD-dependent ROI may trigger callose deposition by regulating either the biosynthesis or deposition of (1/3) b-D-glucan at the cell wall. We propose a model illustrating how HopAI1 suppresses PAMP-induced immunity (Figure 6 ). Upon the perception of PAMPs, MPK3 and MPK6 are activated to regulate two downstream pathways important for disease resistance, the transcription of a large number of genes and callose deposition. The former is probably mediated by transcription factors such as WRKY22 and WRKY29 (Asai et al., 2002) , whereas the latter is synthesized by callose synthase PMR4 (Nishimura et al., 2003; Jacobs et al., 2003) and regulated by the AtrbohD-dependent ROI production. MKK4, MKK5, and MEKK1 were proposed to operate upstream of MPK3 and MPK6 (Asai et al., 2002) , but such a role has yet to be supported by genetic data (Ichimura et al., 2006) . HopAI1 directly dephosphorylates MAPKs through its phosphothreonine lyase activity, thereby inactivating MPK3 and MPK6 and suppressing both PAMPinduced gene transcription and the cell wall defense.
EXPERIMENTAL PROCEDURES

Plants and Bacterial Strains
Arabidopsis thaliana plants used in this study include the wild-type (Col-0), the atrbohD and atrbohF mutants (Torres et al., 2002) , the T-DNA insertional mutants atmpk6 and atmpk3 (a gift from Shuqun Zhang; Liu and Zhang, 2004) , a fast-neutron generated atmpk3 deletion mutant (a gift from Yuelin Zhang), a dexamethasone-inducible MKK5 DD transgenic line (Liu and Zhang, 2004) , and HopAI1-FLAG transgenic plants (Li et al., 2005 (Davis et al., 1991; Kang et al., 2003 inserted into the PCR2.1-TOPO vector (Invitrogen). The resulting plasmid was introduced into strain 0288-9, and kanamycin resistant clones were verified by PCR for successful recombination. The resulting mutant carries a truncated hopAI1 gene lacking the promoter sequence and the N-terminal 35 amino acids required for type III secretion and a second copy of hopAI1 gene lacking the C-terminal 57 amino acids.
Oxidative Burst Untreated or estradiol-induced leaves were sliced into approximately 1 mm strips, incubated in H 2 O in a 24 well plate for 12 hr, and equal amounts of leaf tissues were treated with 1 mM flg22 in 500 ml buffer containing 20 mM luminol and 1 mg horseradish peroxidase (Sigma).
Luminescence was recorded for 20 min by using a low-light imaging system, and relative luminescence was calculated with the WINVIEW software (Roper Scientific).
Flg22-Protection Assay
Five-week-old plants were first infiltrated with 1 mM flg22 or H 2 O one day before infiltrating 10 5 CFU/ml P. syringae DC3000. Leaf bacterial population was determined at the indicated times. In experiments involving transgenic plants carrying the HopAI1 transgene, plants were presprayed with 50 mM estradiol for 12 hr before the flg22 infiltration. Leaf bacterial number was determined at the indicated times after bacterial inoculation. Each data point consisted of at least four replicates.
Callose Staining
Five-week-old Arabidopsis leaves were untreated or presprayed with 50 mM estradiol or H 2 O 12 hr prior to the infiltration of 40 mM flg22. Leaves were removed 12 hr after infiltration, cleared, stained with aniline blue (Hauck et al., 2003) , and mounted in 50% glycerol, and epifluorescence was visualized with a fluorescence microscope under ultraviolet light. The number of callose deposits per microscopic field of 0.1 mm 2 was calculated from six leaves by using the Image J software (http://www.uhnresearch.ca/wcif).
MAPK Assay
The DMEKK1 construct was made by PCR amplifying the kinase catalytic domain from amino acids 326 to 592 (Asai et al., 2002 ) using primers 5 0 -AATGGATCCATGGGAGGAGCTATCATAACGTCTTG-3 0 and 5 0 -ACTGGTCGACTCATGGTAAGGGTCTTCTCACAAATG-3 0 . The resulting PCR product was inserted into pUC19-35S-FLAG-RBS plasmid (Li et al., 2005) predigested with BamHI and ClaI. The MKK5 DD construct for protoplast expression was made by PCR amplifying the pET28-MKK5 DD plasmid (Liu and Zhang, 2004) 
and inserted between
XhoI and Csp45I of the pUC19-35S-FLAG-RBS plasmid. The HopAI1 and AvrPto constructs used for transient expression were described previously (Li et al., 2005) . Protoplasts were isolated from 6-weekold plants and transfected with desired constructs according to a protocol developed by the Sheen lab (http://www.genetics.mgh.harvard. edu_sheenweb). Transfected protoplasts were incubated for 6 hr, and 1 mM flg22 or H 2 O was added for 10 min before protein was extracted for in-gel kinase assay as described (Zhang and Klessig, 1997) . For MAPK assay with leaf tissues, 5-week-old plants were sprayed with 10 mM flg22 or H 2 O containing 0.02% Silwet L-77 for 10 min before protein extraction. Ten micrograms of total protein from leaves or protoplasts was electrophoresed on 12% SDS-polyacrylamide gels embedded with 0.25 mg/ml of myelin basic protein (MBP) in the separating gel as a substrate for the kinase. The perception of flg22 by the receptor FLS2 activates MPK3 and MPK6 that subsequently phosphorylate the yet to be identified substrates to activate WRKY-mediated gene transcription and AtrbohDmediated ROI production and cell wall defenses. HopAI1 binds and dephosphorylates MAPKs through its phosphothreonine lyase activity, and subsequently inhibits down-stream defense responses. Two previously reported effectors, AvrPto and AvrPtoB, target an unknown component(s) upstream of the MAPK cascade. FLS2 may also activate downstream signaling through a MAPK-independent pathway not shown in the model .
The level of HopAI1-FLAG, AvrPto, MPK3, and MPK6 proteins in the extracts was determined by western blot analysis using anti-AvrPto (Shan et al., 2000) , anti-FLAG, anti-MPK3, or anti-MPK6 antibodies (Sigma).
RNA Blot Analysis
Flg22-inducible genes were selected according to microarray data deposited by T. Nü rnberger (http://Arabidopsis.org/info/expression/ ATGenExpress.jsp). Gene specific primers were used to amplify WRKY22, WRKY29, FRK1 (Asai et al., 2002) . Five-week-old plants were infiltrated with H 2 O or 1 mM flg22 for the indicated hours before RNA isolation. RNA blots were hybridized to radio-labeled PCR products for the selected genes.
Expression of Recombinant Proteins in E. coli and Protein Pull-Down Assay
Full length Arabidopsis MPK3 and MPK6 were PCR amplified from cDNA and inserted between the BamHI and XhoI sites of pGEX-6p-1 (Pharmacia) to generate GST-MPK3, GST-MPK6, and NdeI and XhoI of pET28b or pET30a (Novagen) to generate His-MPK3 and MPK6-His constructs. HopAI1 7-245 was PCR-amplified from P. syringae DC3000 genomic DNA and inserted into pGEX-6p-1 plasmid (between BamHI and XhoI) to generate GST-HopAI1 . The respective recombinant proteins were affinity purified following manufactures' instructions.
For protein pull-down assay, His-MPK3 and MPK6-His were coexpressed with GST-HopAI1 . Bacterial lysate was incubated with glutathione agarose in a microcentrifuge tube, washed three times with a buffer containing 25 mM Tris, PH8.0, 50 mM NaCL, and 3 mM DTT. The bound protein was eluted with 15 mM GSH and analyzed by using western blot.
Coimmunoprecipitation Assay
Five-week old plants were sprayed with 50 mM estradiol for 12 hr. Soluble protein was extracted and precipitated with an agarose-conjugated anti-FLAG monoclonal antibody (Sigma) following manufacturer's instruction. Western blot was used to detect the presence of HopAI1-FLAG, MPK3, or MPK6 in the immunocomplex with a monoclonal anti-FLAG antibody, or anti-MPK3 or anti-MPK6 antibodies (Sigma).
Reporter Assay in Protoplasts
Protoplasts were prepared from 6-week-old WT or NHO1-LUC transgenic plants (Li et al., 2005) , transfected with the indicated plasmids, induced with flg22, and examined for LUC activity as described (Li et al., 2005) .
MAPK Phosphorylation and Inactivation In Vitro 0.5 mg purified MKK5 DD -His recombinant protein was incubated with 2 mg GST-MPK3 or GST-MPK6 in a kinase reaction buffer (Liu and Zhang, 2004) at 22 C for 90 min before terminated by the addition of 10 mM EDTA. The phosphorylated GST-MPK3 and GST-MPK6 proteins were incubated with 5 mg purified HopAI1 7-245 or BSA for 10 min, boiled in SDS sample buffer before analyzed by using western blot with anti-phospho-ERK antibodies (Cell Signaling).
Phosphothreonine Lyase Activity Assays Synthetic MAPK phosphopeptide (SESDFM-pTE-pYVVTR; Sangon, Shanghai) was incubated with 5 mg HopAI1 7-245 in a 50 ml reaction buffer containing 10 mM HEPES (pH 7.4), 150 mM NaCl, and 1 mM EDTA and incubated at 30 C, and the release of phosphate group was determined by using Molybdate Dye (Promega). The specific modification of phosphothreonine residue in the HopAI1-treated peptide was determined by mass spectrometry and tandem mass spectrometry analyses.
Supplemental Data
The Supplemental Data include seven supplemental figures and can be found with this article online at http://www.cellhostandmicrobe. com/cgi/content/full/1/3/175/DC1/.
